LGVN Longeveron Inc.

NASDAQ
$0.74

Longeveron Inc. (LGVN) is expected to report earnings on November 11, 2026, after the market close. The consensus earnings estimate is a loss of $0.15 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +10.4% since its last earnings release on August 12, 2026.

Longeveron Reported In-line with Estimates
Wednesday, August 12, 2026 · 4:05 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 11
Wednesday · 4:05 PM ET
Earnings Whisper
-
vs ($0.15)
Rev est $410K
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $0.71

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Longeveron Inc.

Longeveron is a clinical stage biotechnology company developing cellular therapies for specific aging-related and life-threatening conditions.

Sector

Healthcare

Industry

Biotechnology